{
    "clinical_study": {
        "@rank": "83929", 
        "acronym": "CORAC", 
        "arm_group": [
            {
                "arm_group_label": "brain damaged subjects", 
                "arm_group_type": "Experimental", 
                "description": "patients with circumscribed brain injury, selective disorders of cognitive development or degenerative disorders responsible for focal troubles"
            }, 
            {
                "arm_group_label": "healthy volunteers", 
                "arm_group_type": "Sham Comparator", 
                "description": "healthy controls"
            }
        ], 
        "brief_summary": {
            "textblock": "Two groups of subjects will be constitute: (i) patients with circumscribed brain injury\n      (including stroke, vascular malformations, tumor or circumscribed infectious lesions) or\n      degenerative disorders and selective cognitive disorders; (ii) healthy control subjects.\n\n      The objective of this project is to evaluate specific neuropsychological deficits and apply\n      current brain imaging techniques (anatomical, diffusion, functional) to patients suffering\n      from these cognitive deficits due to brain damage, in order to elucidate the brain\n      mechanisms underlying these deficits."
        }, 
        "brief_title": "Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage", 
        "completion_date": {
            "#text": "January 2019", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cerebrovascular Disorders", 
            "Brain Lesions", 
            "Degenerative Diseases", 
            "Developmental Pathology"
        ], 
        "condition_browse": {
            "mesh_term": "Cerebrovascular Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age between 18 and 80 years\n\n          -  french language\n\n          -  effective contraception for women during the study\n\n          -  informed consent\n\n          -  no alcohol intake the day before the exam\n\n          -  for patients only, focal cerebral lesion (stroke, malformation, tumor, inflammatory,\n             infectious, traumatic), neonatal pathology or degenerative disease with cognitive\n             deficit\n\n        Exclusion Criteria:\n\n          -  for healthy volunteers: previous neurological history (except non complicated\n             migraine), previous psychiatric history (except depression with good evolution or\n             anxiety with maximum one anxiolytic treatment), or severe cranial traumatism\n\n          -  for patients: vigilance disorders, severe depression or anxiety.\n\n          -  for both: psychotropic medication other than a hypnotic or an anxiolytic at low doses\n             without dose modification for at least one month, severe visual or auditory\n             impairment, patient without judicial or administrative liberty, measure of legal\n             protection or no capable to express their consent, pregnancy or breastfeeding,\n             contraindication for MRI, participation in another trial or former involvement in\n             another trial within one month"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "280", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01849549", 
            "org_study_id": "2012/191/HP", 
            "secondary_id": "2012-A01332-41"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "brain damaged subjects", 
                    "healthy volunteers"
                ], 
                "description": "Experimental test about cognitive deficit of interest and standard neuropsychological tests.", 
                "intervention_name": "Neuropsychological testing", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "brain damaged subjects", 
                    "healthy volunteers"
                ], 
                "description": "Anatomical, diffusion, and/or functional MRI", 
                "intervention_name": "MRI", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "neuropsychological Study", 
            "brain Imaging"
        ], 
        "lastchanged_date": "June 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rouen", 
                    "country": "France", 
                    "zip": "76031"
                }, 
                "name": "CHU - H\u00f4pitaux de Rouen"
            }, 
            "investigator": {
                "last_name": "Olivier MARTINAUD, Doctor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Anatomical Clinical Correlations. Neuropsychological and Brain Medical Imaging Study in Brain Damaged Subjects.", 
        "overall_contact": {
            "email": "olivier.martinaud@chu-rouen.fr", 
            "last_name": "Olivier MARTINAUD, Doctor", 
            "phone": "2 32 88 87 40", 
            "phone_ext": "+33"
        }, 
        "overall_official": {
            "affiliation": "service de Neurologie", 
            "last_name": "Olivier MARTINAUD, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The cognitive deficit of interest will depend on the localization of the brain lesion. The outcome measure could be a standardized neuropsychological test or an experimental test specifically elaborated for this protocol.", 
            "measure": "Cognitive deficit", 
            "safety_issue": "No", 
            "time_frame": "3 to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01849549"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Hospital, Rouen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Rouen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}